LAS VEGAS — At the Ophthalmology Innovation Summit, Robert Greenberg, MD, chairman of Second Sight, discusses the company’s latest innovations for treating blindness, including information on the Argus II retinal prosthesis system.
Uncategorized
Uncategorized
VIDEO: Update on Allegro’s phase 2b clinical trials
LAS VEGAS — At the Ophthalmology Innovation Summit, Vicken Karageozian, MD, chief technical officer of Allegro Ophthalmics, discusses progress of the company’s Luminate (ALG-1001) program and gives an update on phase 2b clinical trials and use of the integrin peptide across multiple vitreoretinal indications, including vitreomacular traction, diabetic macular edema and posterior vitreous detachment.
Uncategorized
VIDEO: New software facilitates patient follow-up care
LAS VEGAS — At the Ophthalmology Innovation Summit, John A. Hovanesian, MD, FACS, founder of MDbackline, discusses the advantages of the software’s automated patient contact system, which facilitates follow-up care and helps educate patients.
Uncategorized
VIDEO: Small aperture inlay, IOL garnering good visual results
LAS VEGAS — At the Ophthalmology Innovation Summit, Nick Tarantino, OD, chief global clinical research and regulatory affairs officer for AcuFocus, discusses visual results achieved in presbyopia correction with the Kamra inlay as well as the IC-8 IOL in development.
Uncategorized
VIDEO: Shire moves forward with lifitegrast in wake of OPUS 3 results
LAS VEGAS — At the Ophthalmology Innovation Summit, Robert Dempsey, vice president and head of ophthalmology at Shire, discusses the company’s plans moving forward for lifitegrast in dry eye treatment.
Uncategorized
VIDEO: CEO shares new data on Dextenza
LAS VEGAS — At the Ophthalmology Innovation Summit, Amar Sawhney, PhD, president and CEO of Ocular Therapeutix, discusses the latest clinical trial data on Dextenza (sustained-release dexamethasone 0.4 mg) for ocular itching associated with allergic conjunctivitis.